Association of The Lys198asn Polymorphism of The Endothelin-1 (Edn1) Gene with Congenital Malformations in Newborns
Abstract
Objective: To evaluate the distribution of alleles and genotypes of the Lys198Asn (rs5370) polymorphism in the EDN1 gene and determine its association with the risk of various pathogenetic variants of congenital anomalies (CAs) in newborns.
Materials and Methods: A molecular genetic study was conducted on 123 newborns with CAs (main group) and 110 healthy infants (control group) using PCR. Statistical analysis included the Chi-squared test ($\chi^2$), Odds Ratio (OR), and 95% Confidence Interval (95% CI).
Results: Accumulation of the mutant Asn allele was identified in the CA group (23.01% vs. 15.91% in controls), reaching a peak in subgroups with chromosomal pathology (26.47%) and folate-independent CAs (26.19%). The total proportion of Lys/Asn and Asn/Asn carrier genotypes in infants with CAs was 39.82% (vs. 28.18% in controls). A statistically significant association was established between the homozygous Asn/Asn genotype and the risk of CAs with chromosomal pathology (17.65% vs. 3.64% in controls; OR = 5.7; 95% CI: 1.34–24.09). For folate-independent CAs, the Asn/Asn genotype increased the risk by 2.8 times (OR = 2.8; 95% CI: 0,51–15,27). Receiver operating characteristic analysis revealed that the Lys/Asn genotype possesses balanced predictive value for primary screening (AUC = 0.55; OR = 1.56), while the Asn/Asn genotype demonstrates high specificity (SP = 0.96).
Conclusions: The Lys198Asn polymorphism of the EDN1 gene is associated with an increased risk of congenital anomalies in newborns, exerting its strongest effect in cases with chromosomal aberrations and folate-independent CAs. The Asn/Asn genotype serves as a highly specific molecular biomarker for stratifying high reproductive risk groups.
Keywords
Endothelin-1 (EDN1), Lys198Asn polymorphism, gene polymorphism
References
Bebyakova N.A., Levitsky S.N., Shabalina I.A., Fadeeva N.A. Polymorphism of the endothelin-1 type B receptor gene (EDNB) and hemodynamic parameters of vascular tone. Contemporary Issues of Biomedicine. 2023;7(1):23–30. doi:10.51871/2588-0500_2023_07_01_2
World Health Organization. Congenital anomalies [Electronic resource]. 2026. URL: https://www.who.int/ru/news-room/fact-sheets/detail/congenital-anomalies (accessed 20.02.2026).
Degnera E.A., Zueva V.N., Khokhlova D.V. Influence of EDN1 (rs5370), EDNRA (rs6842241), and EDNRB (rs5351) gene polymorphisms on the cardiovascular system. Innovative Science. 2022;5(1):15–18.
Zakharova S.Yu., Levina L.G. Humoral markers of endothelial dysfunction in infants born with intrauterine growth restriction syndrome. Russian Bulletin of Perinatology and Pediatrics. 2019;64(6):57–61. https://doi.org/10.21508/1027-4065-2019-64-6-57-61
Katargina L.A., Chesnokova N.B., Arestova N.N., Sorokin A.A., Pavlenko T.A., Beznos O.V., Lisovskaya O.A. Endothelin-1 content in the tear fluid of children with primary congenital glaucoma. Russian Ophthalmological Journal. 2023;16(1):36–40. https://doi.org/10.21516/2072-0076-2023-16-1-36-40
Timofeev Yu.S., Mikhailova M.A., Dzhioeva O.N., Drapkina O.M. Significance of biological markers in the assessment of endothelial dysfunction. Cardiovascular Therapy and Prevention. 2024;23(9):4061. https://doi.org/10.15829/1728-8800-2024-4061.
Kanai SM, Clouthier DE. Endothelin signaling in development. Development. 2023 Dec 15;150(24):dev201786. doi: 10.1242/dev.201786. Epub 2023 Dec 11. PMID: 38078652; PMCID: PMC10753589.
Mei M, Cheng G, Sun B, Yang L, Wang H, Sun J, Zhou W. EDN1 Gene Variant is Associated with Neonatal Persistent Pulmonary Hypertension. Sci Rep. 2016 Jul 18;6:29877. doi: 10.1038/srep29877. PMID: 27425626; PMCID: PMC4947908.
Yin HL, Luo CW, Dai ZK, Shaw KP, Chai CY, Wu CC. Hypoxia-inducible factor-1α, vascular endothelial growth factor, inducible nitric oxide synthase, and endothelin-1 expression correlates with angiogenesis in congenital heart disease. Kaohsiung J Med Sci. 2016 Jul;32(7):348-55. doi: 10.1016/j.kjms.2016.05.011. Epub 2016 Jun 25. PMID: 27450023; PMCID: PMC13042545.
Download and View Statistics
Copyright License
Copyright (c) 2026 Gulnaz Abdiualievna Kamalova, Nargiza Karimovna Khodjamova, Karimov Kh.Ya., Boboev K.T.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Medical Science
| Open Access |
DOI: